Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Practically Speaking: Napoli - The Use of Nal-IRI in Daily Practice

  • Broadcast in Medicine



Follow This Show

If you liked this show, you should follow MedOncNow.

To be added to the distribution list, please email: DDeCastro@southlakeregional.org

In this episode, Dr. Daniel Renouf takes us through the use of Onivyde (NanoLiposomal Irinotecan)  in the contemporary management of Pancreatic Ductal Adenocarcinoma.  We touch on the use of Nal-Iri in the 2nd line and beyond as well as the first line setting. 

Key Opinion Leader: 
Dr. Daniel Renouf  MD. MPH. FRCPC
Assistant Professor, UBC
Medical Ongologist, BC Cancer. 

Shaqil Kassam MD. MSc. FRCPC
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Previous episodes: https://www.blogtalkradio.com/medoncnow
X @medoncnow

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled